Chronic migraine with and without chronic insomnia
https://doi.org/10.21518/ms2025-298
Abstract
Introduction. Identification of the characteristics of patients with chronic migraine (CM) and comorbid chronic insomnia (CI) can improve the quality of management for such patients.
Aim. To compare the socio-demographic and clinical-psychological characteristics of patients with CM combined with and without CI, assess the relationship between insomnia and clinical-psychological characteristics in this category of patients.
Materials and methods. The study included 200 patients with CM combined with and without CI (63 men and 137 women, mean age 33.1 ± 7.1 years), who were divided into Group 1 (96 patients with CM and CI) and Group 2 (104 patients with CM without CI). All patients underwent clinical interviews, testing, neurological and somatic examinations.
Results. There were significantly (p < 0.05) fewer patients who were married, more often divorced and had drug-induced headache and neck pain in Group 1 as compared to Group 2. The frequency of intake and number of doses of pain medications (PM), personal anxiety, depression, rumination, insomnia severity, PM dependence, emotion-focused coping, and pericranial muscle soreness were significantly higher in Group 1 compared to Group 2, whereas adherence to treatment was significantly lower. Insomnia has been shown to correlate significantly positive with the frequency of intake and number of doses of PMs, personal anxiety, depression, rumination, PM dependence, emotion-focused coping, pericranial muscle soreness, and negative correlation with treatment adherence.
Conclusion. In CM, a positive correlation was established between insomnia and the frequency of intake and number of doses of PM, PM dependence, personal anxiety, depression, rumination, emotion-focused coping, pericranial muscle soreness, and a negative correlation between insomnia and treatment adherence, which should be taken into account when managing patients.
About the Authors
V. A. GolovachevaRussian Federation
Veronika A. Golovacheva - Cand. Sci. (Med.), Associate Professor of the Department of Nervous Diseases and Neurosurgery, Sklifosovsky Institute of Clinical Medicine.
8, Bldg. 2, Trubetskaya St., Moscow, 119991
I. A. Strokov
Russian Federation
Igor А. Strokov - Cand. Sci. (Med.), Associate Professor of the Department, Sklifosovsky Institute of Clinical Medicine.
8, Bldg. 2, Trubetskaya St., Moscow, 119991
References
1. Kung D, Rodriguez G, Evans R. Chronic Migraine: Diagnosis and Management. Neurol Clin. 2023;41(1):141–159. https://doi.org/10.1016/j.ncl.2022.05.005.
2. Steiner TJ, Birbeck GL, Jensen RH, Katsarava Z, Stovner LJ, Martelletti P. Headache disorders are third cause of disability worldwide. J Headache Pain. 2015;16:58. https://doi.org/10.1186/s10194-015-0544-2.
3. Burch RC, Buse DC, Lipton RB. Migraine: Epidemiology, Burden, and Comor bidity. Neurol Clin. 2019;37(4):631–649. https://doi.org/10.1016/j.ncl.2019.06.001.
4. Agostoni EC, Barbanti P, Calabresi P, Colombo B, Cortelli P, Frediani F et al. Current and emerging evidence-based treatment options in chronic migraine: a narrative review. J Headache Pain. 2019;20(1):92. https://doi.org/10.1186/s10194-019-1038-4.
5. Golovacheva VA, Golovacheva AA, Tarshilova AR, Osipova VV. Diagnosis of chronic migraine and comorbid neurological disorders in real-life clinical practice. Neurology, Neuropsychiatry, Psychosomatics. 2024;16(Suppl. 1):23–30. (In Russ.) https://doi.org/10.14412/2074-2711-2024-1S-23-30.
6. Golovacheva VA, Golovacheva AA, Romanov DV, Volodarskaya EA. Mental disorders, social and demographic characteristics of patients with chronic and episodic migraine. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2024;124(1):94–101. (In Russ.)https://doi.org/10.17116/jnevro202412401194.
7. Kniazeva IaA, Gilev DV, Osipova VV, Lebedeva ER. Demographic and comorbid factors associated with the development of medication overuse headache. Neurology, Neuropsychiatry, Psychosomatics. 2024;16(Suppl. 1):12–18. (In Russ.) https://doi.org/10.14412/2074-2711-2024-1S-12-18.
8. Guziy EA, Sergeev AV, Tabeeva GR. Clinical and psychoemotional characteristics of patients with medication overuse headache. Neurology, Neuropsychiatry, Psychosomatics. 2024;16(Suppl. 1):52–58. (In Russ.) https://doi.org/10.14412/2074-2711-2024-1S-52-58.
9. Lin YK, Lin GY, Lee JT, Lee MS, Tsai CK, Hsu YW et al. Associations Between Sleep Quality and Migraine Frequency: A Cross-Sectional Case-Control Study. Medicine. 2016;95(17):e3554. https://doi.org/10.1097/MD.0000000000003554.
10. Yang CP, Wang SJ. Sleep in Patients with Chronic Migraine. Curr Pain Headache Rep. 2017;21(9):39. https://doi.org/10.1007/s11916-017-0641-9.
11. Kelman L, Rains JC. Headache and sleep: examination of sleep patterns and complaints in a large clinical sample of migraineurs. Headache. 2005;45(7):904–910. https://doi.org/10.1111/j.1526-4610.2005.05159.x.
12. Tabeeva GR, Osipova VV, Filatova EG, Azimova YuE, Amelin AV, Artyomenko AR et al. Evaluation and treatment of medication-overuse headache: Russian experts’ guidelines. Neurology, Neuropsychiatry, Psychosomatics. 2022;14(1):4–13. (In Russ.) https://doi.org/10.14412/2074-2711-2022-1-4-13.
13. Ong JC, Park M. Chronic headaches and insomnia: working toward a biobehavioral model. Cephalalgia. 2012;32(14):1059–1070. https://doi.org/10.1177/0333102412455709.
14. Filatova EG, Osipova VV, Tabeeva GR, Parfenov VA, Ekusheva EV, Azimova YuE et al. Diagnosis and treatment of migraine: Russian experts’ recommendations. Neurology, Neuropsychiatry, Psychosomatics. 2020;12(4):4–14. (In Russ.) https://doi.org/10.14412/2074-2711-2020-4-4-14.
15. Golovacheva VA. Treatment of chronic migraine and insomnia with cognitive behavioral therapy. Meditsinskiy Sovet. 2023;17(3):68–76. (In Russ.) https://doi.org/10.21518/ms2023-080.
16. Golovacheva VA, Golovacheva AA. Treatment of insomnia in elderly patients with headaches. Meditsinskiy Sovet. 2023;17(21):44–52. (In Russ.) https://doi.org/10.21518/ms2023-411.
17. Golovacheva VA, Golovacheva AA, Fateeva TG, Parfenov VA. Cognitive behavioral therapy in the treatment of patients with chronic migraine and concomitant chronic insomnia: a prospective, randomized trial. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2024;124(5-2):110–117. (In Russ.) https://doi.org/10.17116/jnevro2024124052110.
18. Golovacheva VA, Golovacheva AA, Tarshilova AR, Osipova VV. Typical clinical practice of treating patients with chronic migraine. Neurology, Neuropsychiatry, Psychosomatics. 2024;16(Suppl. 1):31–37. (In Russ.) https://doi.org/10.14412/2074-2711-2024-1S-31-37.
19. Sergeev AV, Guziy EA, Kovalchuk NA, Sokolov EA, Grigoriev GV, Tabeeva GR. Comparative analysis of the efficacy of different treatment strategies in medication overuse headache: an open-label prospective trial. Neurology, Neuropsychiatry, Psychosomatics. 2024;16(Suppl. 1):45–51. (In Russ.) https://doi.org/10.14412/2074-2711-2024-1S-45-51.
20. Tabeeva GR, Filatova EG, Amelin AV, Osipova VV, Artemenko AR, Akhmadeeva LR et al. Alternative and complementary treatments for migraine. Neurology, Neuropsychiatry, Psychosomatics. 2024;16(1):4–15. (In Russ.) https://doi.org/10.14412/2074-2711-2024-1-4-15.
21. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd ed. Cephalalgia. 2018;38(1):1–211. https://doi.org/10.1177/0333102417738202.
22. Riemann D, Espie CA, Altena E, Arnardottir ES, Baglioni C, Bassetti CLA et al. The European Insomnia Guideline: An update on the diagnosis and treatment of insomnia 2023. J Sleep Res. 2023;32(6):e14035. https://doi.org/10.1111/jsr.14035.
23. Poluektov MG, Buzunov RV, Averbukh VM, Verbitskiy EV, Zakharov AV, Kel’manson IA et al. Project of clinical recommendations on diagnosis and treatment of chronic insomnia in adults. Consilium Medicum. Neurology and Rheumatology (Suppl.). 2016;(2):41–51. (In Russ.) Available at: https://www.rnmot.ru/public/uploads/2020/RNMOT/Клинические%20рекомендации%20по%20инсомнии.pdf.
24. Modarresi S, Lukacs MJ, Ghodrati M, Salim S, MacDermid JC, Walton DM. A Systematic Review and Synthesis of Psychometric Properties of the Numeric Pain Rating Scale and the Visual Analog Scale for Use in People With Neck Pain. Clin J Pain. 2021;38(2):132–148. https://doi.org/10.1097/AJP.0000000000000999.
25. Morin CM, Belleville G, Bélanger L, Ivers H. The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep. 2011;34(5):601–608. https://doi.org/10.1093/sleep/34.5.601.
26. Ikemoto T, Hayashi K, Shiro Y, Arai YC, Marcuzzi A, Costa D, Wrigley P. A systematic review of cross-cultural validation of the pain catastrophizing scale. Eur J Pain. 2020;24(7):1228–1241. https://doi.org/10.1002/ejp.1587.
27. Bados A, Gómez-Benito J, Balaguer G. The state-trait anxiety inventory, trait version: does it really measure anxiety? J Pers Assess. 2010;92(6):560–567. https://doi.org/10.1080/00223891.2010.513295.
28. Henry SK, Grant MM, Cropsey KL. Determining the optimal clinical cutoff on the CES-D for depression in a community corrections sample. J Affect Disord. 2018;234:270–275. https://doi.org/10.1016/j.jad.2018.02.071.
29. Wang YF, Tzeng YS, Yu CC, Ling YH, Chen SP, Lai KL, Wang SJ. Clinical Utility of Leeds Dependence Questionnaire in Medication-Overuse Headache. Diagnostics. 2023;13(3):472. https://doi.org/10.3390/diagnostics13030472.
30. Van Horn JE, Wilpert J. Full and Short Versions of the Coping Inventory for Stressful Situations and Social Problem-Solving Inventory-Revised: Examining Their Factor Structure in a Dutch Outpatient Sex Offender Sample. Psychol Rep. 2017;120(4):739–759. https://doi.org/10.1177/0033294117702362.
31. Stewart WF, Lipton RB, Dowson AJ, Sawyer J. Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability. Neurology. 2001;56(6 Suppl. 1):S20–S28. https://doi.org/10.1212/wnl.56.suppl_1.s20.
32. Nikolayev NA, Skirdenko YuP. Russian generic questionnaire for evaluation of compliance to drug therapy. Clinical Pharmacology and Therapy. 2018;27(1):74–78. (In Russ.) Available at: https://clinpharm-journal.ru/ articles/2018-1/rossijskij-universalnyj-oprosnik-kolichestvennoj-otsenki-priverzhennosti-k-lecheniyu-kop-25/.
33. Ferrari A, Leone S, Vergoni AV, Bertolini A, Sances G, Coccia CP et al. Similarities and differences between chronic migraine and episodic migraine. Headache. 2007;47(1):65–72. https://doi.org/10.1111/j.1526-4610.2006.00629.x.
34. Latysheva NV, Filatova EG, Osipova DV. Chronic pain, depression and cognitive impairment: a close relationship. Nervno-Myshechnye Bolezni. 2018;8(3):34–42. (In Russ.) https://doi.org/10.17650/2222-8721-2018-8-3-34-42.
35. Artemenko AR, Kurenkov AL, Belomestova KV. Classification, diagnosis and treatment of chronic migraine: review of new data. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2013;113(11):91–96. (In Russ.) Available at: https://www.mediasphera.ru/issues/zhurnal-nevrologiii-psikhiatrii-im-s-s-korsakova/2013/11/031997-7298201311017.
36. Katsarava Z, Buse DC, Manack AN, Lipton RB. Defining the differences between episodic migraine and chronic migraine. Curr Pain Headache Rep. 2012;16(1):86–92. https://doi.org/10.1007/s11916-011-0233-z.
37. Adams AM, Serrano D, Buse DC, Reed ML, Marske V, Fanning KM, Lipton RB. The impact of chronic migraine: The Chronic Migraine Epidemiology and Outcomes (CaMEO) Study methods and baseline results. Cephalalgia. 2015;35(7):563–578. https://doi.org/10.1177/0333102414552532.
38. Buse DC, Manack A, Serrano D, Turkel C, Lipton RB. Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J Neurol Neurosurg Psychiatry. 2010;81(4):428–432. https://doi.org/10.1136/jnnp.2009.192492.
39. Blumenfeld AM, Varon SF, Wilcox TK, Buse DC, Kawata AK, Manack A et al. Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS). Cephalalgia. 2011;31(3):301–315. https://doi.org/10.1177/0333102410381145.
40. Torres-Ferrús M, Ursitti F, Alpuente A, Brunello F, Chiappino D, de Vries T et al. From transformation to chronification of migraine: pathophysiological and clinical aspects. J Headache Pain. 2020;21(1):42. https://doi.org/10.1186/s10194-020-01111-8.
41. Golovacheva VA, Golovacheva AA, Fateeva TG, Volodarskaya EA. Illness perception in patients with chronic migraine: cognitive, emotional and behavioral aspects. Neurology, Neuropsychiatry, Psychosomatics. 2023;15(1):28–35. (In Russ.) https://doi.org/10.14412/2074-2711-2023-1-28-35.
Review
For citations:
Golovacheva VA, Strokov IA. Chronic migraine with and without chronic insomnia. Meditsinskiy sovet = Medical Council. 2025;(12):30-37. (In Russ.) https://doi.org/10.21518/ms2025-298